TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Genedrive ( (GB:GDR) ) has shared an update.
Genedrive plc announced it will release its preliminary financial results for the year ending June 2025 on December 5, 2025. The company will host a live investor presentation on December 8, 2025, led by CEO Gino Miele and CFO Russ Shaw. This announcement underscores Genedrive’s commitment to transparency and engagement with its investors, as it continues to focus on growth through in-market sales, geographic expansion, and strategic mergers and acquisitions.
The most recent analyst rating on (GB:GDR) stock is a Hold with a £1.50 price target. To see the full list of analyst forecasts on Genedrive stock, see the GB:GDR Stock Forecast page.
Spark’s Take on GB:GDR Stock
According to Spark, TipRanks’ AI Analyst, GB:GDR is a Neutral.
Genedrive is navigating profitability challenges despite strong revenue growth and a solid balance sheet. Technical analysis indicates bearish momentum, while valuation metrics are unappealing due to lack of profitability. However, recent corporate developments are promising, potentially enhancing market positioning and future prospects.
To see Spark’s full report on GB:GDR stock, click here.
More about Genedrive
Genedrive plc is a UK-based pharmacogenetic testing company specializing in point of care solutions. It develops and commercializes rapid, low-cost, and easy-to-use diagnostic platforms for genetic variant detection, aiding clinicians in personalized medicine decisions. The company is known for its Genedrive® MT-RNR1 and CYP2C19 ID Kits, which are used in emergency healthcare settings to improve patient outcomes.
Average Trading Volume: 57,522,584
Technical Sentiment Signal: Sell
Current Market Cap: £10.3M
See more data about GDR stock on TipRanks’ Stock Analysis page.